Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.
Adult
Aged
Animals
Cerebral Cortex
/ metabolism
Female
Gray Matter
/ metabolism
Humans
Male
Middle Aged
Multiple Sclerosis, Chronic Progressive
/ pathology
Necroptosis
/ physiology
Neurons
/ pathology
Rats
Receptors, Tumor Necrosis Factor
/ metabolism
Signal Transduction
/ physiology
Tumor Necrosis Factor-alpha
/ metabolism
Apoptosis
Cytokines
Meninges
Necroptosis
Neurodegeneration
Journal
Acta neuropathologica
ISSN: 1432-0533
Titre abrégé: Acta Neuropathol
Pays: Germany
ID NLM: 0412041
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
12
09
2020
accepted:
21
01
2021
revised:
06
01
2021
pubmed:
12
2
2021
medline:
16
11
2021
entrez:
11
2
2021
Statut:
ppublish
Résumé
Sustained exposure to pro-inflammatory cytokines in the leptomeninges is thought to play a major role in the pathogenetic mechanisms leading to cortical pathology in multiple sclerosis (MS). Although the molecular mechanisms underlying neurodegeneration in the grey matter remain unclear, several lines of evidence suggest a prominent role for tumour necrosis factor (TNF). Using cortical grey matter tissue blocks from post-mortem brains from 28 secondary progressive MS subjects and ten non-neurological controls, we describe an increase in expression of multiple steps in the TNF/TNF receptor 1 signaling pathway leading to necroptosis, including the key proteins TNFR1, FADD, RIPK1, RIPK3 and MLKL. Activation of this pathway was indicated by the phosphorylation of RIPK3 and MLKL and the formation of protein oligomers characteristic of necrosomes. In contrast, caspase-8 dependent apoptotic signaling was decreased. Upregulation of necroptotic signaling occurred predominantly in macroneurons in cortical layers II-III, with little expression in other cell types. The presence of activated necroptotic proteins in neurons was increased in MS cases with prominent meningeal inflammation, with a 30-fold increase in phosphoMLKL+ neurons in layers I-III. The density of phosphoMLKL+ neurons correlated inversely with age at death, age at progression and disease duration. In vivo induction of chronically elevated TNF and INFγ levels in the CSF in a rat model via lentiviral transduction in the meninges, triggered inflammation and neurodegeneration in the underlying cortical grey matter that was associated with increased neuronal expression of TNFR1 and activated necroptotic signaling proteins. Exposure of cultured primary rat cortical neurons to TNF induced necroptosis when apoptosis was inhibited. Our data suggest that neurons in the MS cortex are dying via TNF/TNFR1 stimulated necroptosis rather than apoptosis, possibly initiated in part by chronic meningeal inflammation. Neuronal necroptosis represents a pathogenetic mechanism that is amenable to therapeutic intervention at several points in the signaling pathway.
Identifiants
pubmed: 33569629
doi: 10.1007/s00401-021-02274-7
pii: 10.1007/s00401-021-02274-7
pmc: PMC7952371
doi:
Substances chimiques
Receptors, Tumor Necrosis Factor
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-604Références
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
J Neuropathol Exp Neurol. 2010 Oct;69(10):1017-1033
pubmed: 20838243
Nat Rev Neurosci. 2015 Mar;16(3):147-58
pubmed: 25697158
Cell Death Differ. 2020 Apr;27(4):1169-1185
pubmed: 31591470
Ann Neurol. 2018 Apr;83(4):739-755
pubmed: 29518260
Nat Rev Drug Discov. 2020 Aug;19(8):553-571
pubmed: 32669658
Brain. 2016 Mar;139(Pt 3):807-15
pubmed: 26912645
Acta Neuropathol. 2011 Aug;122(2):155-70
pubmed: 21626034
Neuron. 2014 Mar 5;81(5):1001-1008
pubmed: 24508385
Brain. 2013 Dec;136(Pt 12):3596-608
pubmed: 24176976
Brain. 2020 Jul 1;143(7):2073-2088
pubmed: 32577755
J Neuroinflammation. 2019 Dec 7;16(1):259
pubmed: 31810488
Nat Cell Biol. 2018 Feb;20(2):186-197
pubmed: 29358703
Nat Neurosci. 2017 Sep;20(9):1236-1246
pubmed: 28758999
Brain. 2013 Jun;136(Pt 6):1799-815
pubmed: 23687122
Acta Neuropathol. 2018 Apr;135(4):511-528
pubmed: 29441412
JAMA Neurol. 2015 Sep;72(9):1004-12
pubmed: 26192316
Nat Rev Immunol. 2015 Sep 15;15(9):545-58
pubmed: 26250739
Cell Rep. 2018 Feb 20;22(8):2066-2079
pubmed: 29466734
Nat Rev Mol Cell Biol. 2013 Nov;14(11):727-36
pubmed: 24129419
Ann Neurol. 2010 Oct;68(4):477-93
pubmed: 20976767
J Biol Chem. 2002 Mar 15;277(11):9505-11
pubmed: 11734559
Brain. 2007 Apr;130(Pt 4):1089-104
pubmed: 17438020
Nat Commun. 2017 Feb 08;8:14329
pubmed: 28176780
Nat Immunol. 2009 Apr;10(4):348-55
pubmed: 19295631
Brain. 2016 Jan;139(Pt 1):39-46
pubmed: 26667278
Ann Neurol. 2020 Sep;88(3):562-573
pubmed: 32418239
PLoS One. 2013 Oct 02;8(10):e76841
pubmed: 24098568
Brain. 2011 Sep;134(Pt 9):2722-35
pubmed: 21908876
Trends Neurosci. 2012 Oct;35(10):638-47
pubmed: 22749718
Nature. 2011 Mar 17;471(7338):368-72
pubmed: 21368762
Brain. 2009 May;132(Pt 5):1175-89
pubmed: 19339255
Nat Immunol. 2011 Nov 16;12(12):1143-9
pubmed: 22089220
Acta Neuropathol Commun. 2020 May 12;8(1):66
pubmed: 32398070
Cell Rep. 2014 May 22;7(4):971-81
pubmed: 24813885
Brain. 2011 Sep;134(Pt 9):2755-71
pubmed: 21840891
Cell Death Differ. 2016 Feb;23(2):253-60
pubmed: 26184911
Ann Neurol. 2008 Sep;64(3):247-54
pubmed: 18570297
N Engl J Med. 1991 Aug 15;325(7):467-72
pubmed: 1852181
Nat Rev Neurosci. 2019 Jan;20(1):19-33
pubmed: 30467385
Ann Neurol. 2008 Sep;64(3):255-65
pubmed: 18661561
Cell. 2012 Jul 20;150(2):339-50
pubmed: 22817896
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Acta Neuropathol. 2012 Dec;124(6):893-903
pubmed: 22864814
Commun Biol. 2018 Jan 22;1:6
pubmed: 30271893
Cell. 2012 Jan 20;148(1-2):213-27
pubmed: 22265413
Brain Pathol. 2020 May;30(3):641-652
pubmed: 31916298
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Neurosci. 2019 Jul;22(7):1046-1052
pubmed: 31182869
Sci Rep. 2017 Oct 20;7(1):13646
pubmed: 29057962
Nature. 2019 Sep;573(7772):75-82
pubmed: 31316211
Brain. 2002 Oct;125(Pt 10):2202-12
pubmed: 12244078
J Neurosci. 2016 May 4;36(18):5128-43
pubmed: 27147664
Acta Neuropathol. 2020 Mar;139(3):463-484
pubmed: 31802237
Cell Rep. 2015 Mar 24;10(11):1836-49
pubmed: 25801023
Cell. 2020 Mar 19;180(6):1115-1129.e13
pubmed: 32200799
Inflamm Res. 2019 Dec;68(12):1049-1059
pubmed: 31559449
JCI Insight. 2019 Dec 19;4(24):
pubmed: 31852844
Brain. 2012 Oct;135(Pt 10):2952-61
pubmed: 23065788
Brain Pathol. 2018 Sep;28(5):735-742
pubmed: 30020563
Neuroscience. 2015 Aug 27;302:2-22
pubmed: 26117714
Nat Neurosci. 2001 Nov;4(11):1116-22
pubmed: 11600888
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
pubmed: 20823910
Cell Res. 2014 Jan;24(1):105-21
pubmed: 24366341
Lancet Neurol. 2018 Oct;17(10):870-884
pubmed: 30143361
Immunol Res. 2012 Dec;54(1-3):214-26
pubmed: 22477525